MUKHERJEE; Siddhartha

Patent Applications and Registrations

Patent applications and USPTO patent grants for MUKHERJEE; Siddhartha.The latest application filed is for "anti-cd33 and nkg2d ligand chimeras for treatment of myeloid malignancies".

Company Profile

11.7.15

MUKHERJEE; Siddhartha - New York NY
Mukherjee; Siddhartha - Pittsburgh PA
MUKHERJEE; Siddhartha - Bangalore IN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Anti-cd33 And Nkg2d Ligand Chimeras For Treatment Of Myeloid Malignancies App 20210393685 - MUKHERJEE; Siddhartha ; et al.	2021-12-23
Crack insertion in implicit non-linear finite deformation analysis Grant 11,127,207 - Wang , et al. September 21, 2	2021-09-21
Methods And Systems For Enabling A Digital Assistant To Generate An Ambient Aware Response App 20210287675 - MUKHERJEE; Siddhartha ; et al.	2021-09-16
Compositions And Methods For Inhibition Of Lineage Specific Antigens App 20210260130 - MUKHERJEE; Siddhartha ; et al.	2021-08-26
Compositions And Methods For Inhibition Of Lineage Specific Antigens App 20210252073 - Mukherjee; Siddhartha ; et al.	2021-08-19
Combination Therapy For Pi3k-associated Disease Or Disorder App 20210236501 - Cantley; Lewis C. ; et al.	2021-08-05
Crack Insertion In Implicit Non-linear Finite Deformation Analysis App 20210043001 - Wang; Jin ; et al.	2021-02-11
Compositions and methods for inhibition of lineage specific antigens Grant 10,912,799 - Mukherjee , et al. February 9, 2	2021-02-09
Compositions and methods for inhibition of lineage specific antigens Grant 10,786,535 - Mukherjee , et al. September 29, 2	2020-09-29
Compositions And Methods For Inhibition Of Lineage Specific Antigens App 20200276244 - Mukherjee; Siddhartha ; et al.	2020-09-03
Cd33 Exon 2 Deficient Donor Stem Cells For Use With Cd33 Targeting Agents App 20200262891 - MUKHERJEE; Siddhartha ; et al.	2020-08-20
Compositions and methods for inhibition of lineage specific antigens Grant 10,668,103 - Mukherjee , et al.	2020-06-02
Compositions and methods for inhibition of lineage specific antigens Grant 10,660,919 - Mukherjee , et al.	2020-05-26
Osteochondroreticular stem cells for bone and cartilage regeneration Grant 10,479,977 - Wang , et al. Nov	2019-11-19
Compositions And Methods For Inhibition Of Lineage Specific Antigens App 20190321410 - Mukherjee; Siddhartha ; et al.	2019-10-24
Compositions And Methods For Inhibition Of Lineage Specific Antigens App 20190314418 - Mukherjee; Siddhartha ; et al.	2019-10-17
Compositions And Methods For Inhibition Of Lineage Specific Antigens App 20190046580 - Mukherjee; Siddhartha ; et al.	2019-02-14
Compositions And Methods For Inhibition Of Lineage Specific Antigens App 20190046581 - Mukherjee; Siddhartha ; et al.	2019-02-14
Compositions and methods for inhibition of lineage specific antigens Grant 10,137,155 - Mukherjee , et al. November 27, 2	2018-11-27
Osteochondroreticular Stem Cells for Bone and Cartilage Regeneration App 20170335283 - WANG; Timothy ; et al.	2017-11-23
Compositions And Methods For Inhibition Of Lineage Specific Antigens App 20170326179 - Mukherjee; Siddhartha	2017-11-16
Compounds And Methods For Targeting Leukemic Stem Cells App 20130338092 - Hartwell; Kimberly ; et al.	2013-12-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.